drugset / Trial / NCT00521131

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

NCT00521131

Phase 4 Completed 453 enrolled UCB Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust Mites

Timeline

Start
2002-09
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levocetirizine Unknown